Webinar: Onco-Hu® Mice for Evaluation of Immuno-Oncology Therapeutics

Join this webinar to learn about cutting edge preclinical mouse platforms used to evaluate immuno-modulatory therapies for human cancer. Discussion topics include:

• Overview of Onco-Hu® mice (tumor bearing hu-NSG™ and hu-NSG™-SGM3)
• Growth kinetics of patient derived tumors (PDX) in NSG™ vs. hu-NSG™
• Comparison of human immune reconstitution in NSG™ vs. NSG™-SGM3 mice
• Therapeutic response to chemotherapy and an anti-PD1 check-point inhibitor in Onco-Hu® mice